Ülke: Birleşik Krallık
Dil: İngilizce
Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)
Codeine phosphate
Sun Pharma UK Ltd
R05DA04
Codeine phosphate
15mg
Oral tablet
Oral
Schedule 5 (CD Inv)
Valid as a prescribable product
BNF: 04070200; GTIN: 8718531945340 8718531945333
V005 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CODEINE PHOSPHATE TABLETS BP 15 MG CODEINE PHOSPHATE TABLETS BP 30 MG Codeine phosphate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Codeine Phosphate Tablets are and what they are used for 2. What you need to know before you take Codeine Phosphate Tablets 3. How to take Codeine Phosphate Tablets 4. Possible side effects 5. How to store Codeine Phosphate Tablets 6. Contents of the pack and other information 1. WHAT CODEINE PHOSPHATE TABLETS ARE AND WHAT THEY ARE USED FOR Codeine Phosphate Tablets contain codeine phosphate. Codeine belongs to a group of medicines called opioid analgesics which act to relieve pain. It can be used on its own or in combination with other pain killers such as paracetamol. Codeine Phosphate Tablets are used in adults for: - relief of pain - relief of coughing - symptomatic relief of prolonged loose stools (diarrhoea) Codeine can be used in children over 12 years of age for the short-term relief of moderate pain that is not relieved by other painkillers such as paracetamol or ibuprofen alone. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CODEINE PHOSPHATE TABLETS DO NOT TAKE CODEINE PHOSPHATE TABLETS IF YOU: - are allergic to codeine phosphate or any of the other ingredients of this medicine (listed in section 6) - have suffered a head injury or raised pressure in the skull (may cause painful eyes, changes in vision or headache behind the eyes) - have liver failure - have severe breathing problems or other chronic lung dis Belgenin tamamını okuyun
OBJECT 1 CODEINE PHOSPHATE TABLETS BP 15MG Summary of Product Characteristics Updated 25-Apr-2018 | Ranbaxy (UK) Limited a Sun Pharmaceutical Company 1. Name of the medicinal product Codeine Phosphate Tablets BP 15mg 2. Qualitative and quantitative composition Each tablet contains 15mg of codeine phosphate Excipients with known effect: Each tablet contains 28.85mg of lactose. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Tablet White to off white circular normal biconvex tablets, embossed with R114. 4. Clinical particulars 4.1 Therapeutic indications Codeine is indicated in adults as an analgesic, an anti-tussive, and for the symptomatic treatment of chronic diarrhoea. Codeine is indicated in patients older than 12 years for the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen alone. 4.2 Posology and method of administration POSOLOGY: As an analgesic: Adults: 30-60mg every four hours, when necessary to a maximum 240mg daily. Elderly: Dosage should be reduced in the elderly where there is impairment of hepatic or renal function. As an anti-tussive: Adults: 15-30mg three or four times daily. Elderly: Dosage should be reduced in the elderly where there is impairment of hepatic or renal function. For the symptomatic treatment of chronic diarrhoea: Adults: 15-60mg every four to six hours. Elderly: Dosage should be reduced in the elderly where there is impairment of hepatic or renal function. Codeine should be used at the lowest effective dose for the shortest period of time. This dose may be taken up to 4 times a day at intervals of not less than 6 hours. Maximum daily dose of codeine should not exceed 240mg. The duration of treatment should be limited to 3 days and if no effective pain relief is achieved the patients/carers should be advised to seek the views of a physician. Paediatric population _Children over 12 years _ 30-60mg every four hours, when necessary to a maximum 240mg daily. _Children aged 12 years to 18 Belgenin tamamını okuyun